0 false false false false false false false true false false true false false false false false false No description of principal activity 2023-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 101 101 101 xbrli:pure xbrli:shares iso4217:GBP 12196671 2023-01-01 2023-12-31 12196671 2023-12-31 12196671 2022-12-31 12196671 2022-01-01 2022-12-31 12196671 2022-12-31 12196671 2021-12-31 12196671 bus:Director1 2023-01-01 2023-12-31 12196671 core:WithinOneYear 2023-12-31 12196671 core:WithinOneYear 2022-12-31 12196671 core:ShareCapital 2023-12-31 12196671 core:ShareCapital 2022-12-31 12196671 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 12196671 core:Non-currentFinancialInstruments 2023-12-31 12196671 core:Non-currentFinancialInstruments 2022-12-31 12196671 bus:SmallEntities 2023-01-01 2023-12-31 12196671 bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 12196671 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 12196671 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 12196671 bus:FullAccounts 2023-01-01 2023-12-31 12196671 1 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: 12196671
Ascendal Finance Limited
Filleted Unaudited Accounts
31 December 2023
Ascendal Finance Limited
Statement of Financial Position
31 December 2023
2023
2022
Note
£
£
Fixed assets
Investments
5
101
101
Current assets
Debtors
6
100
100
Creditors: amounts falling due within one year
7
101
101
----
----
Net current liabilities
1
1
----
----
Total assets less current liabilities
100
100
----
----
Capital and reserves
Called up share capital
100
100
----
----
Shareholders funds
100
100
----
----
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts .
These accounts were approved by the board of directors and authorised for issue on 1 October 2024 , and are signed on behalf of the board by:
A D Leishman
Director
Company registration number: 12196671
Ascendal Finance Limited
Notes to the Accounts
Year ended 31 December 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 2 Rowles Way, Buckingway Business Park, Swavesey, CB24 4UG, England.
2. Statement of compliance
These accounts have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The accounts have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The accounts are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. Its financial statements are consolidated into the financial statements of Ascendal Group Limited which can be obtained from 2 Rowles Way, Buckingway Business Park, Swavesey, England, CB24 4UG. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) Disclosures in respect of each class of share capital have not been presented. (b) No cash flow statement has been presented for the company. (c) Disclosures in respect of financial instruments have not been presented. (d) Disclosures in respect of share-based payments have not been presented. (e) No disclosure has been given for the aggregate remuneration of key management personnel .
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these accounts. There have been no movements in shareholders funds during the current year or prior year.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. These estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employees
There were no employees of the company during the year (2022: nil).
5. Investments
Shares in group undertakings
£
Cost
At 1 January 2023 and 31 December 2023
101
----
Impairment
At 1 January 2023 and 31 December 2023
----
Carrying amount
At 31 December 2023
101
----
At 31 December 2022
101
----
The fixed asset investment held during the year is a 100% subsidiary holding in Ascendal Mexico, S de RL de CV, a company registered and incorporated in Mexico.
6. Debtors
2023
2022
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
100
100
----
----
7. Creditors: amounts falling due within one year
2023
2022
£
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
101
101
----
----
8. Events after the end of the reporting period
Subsequent to the balance sheet date the company disposed of its investment in its subsidiary company, Ascendal Mexico S de RL de CV, a company incorporated in Mexico.
9. Controlling party
The company is a wholly owned subsidiary of Ascendal Group Limited , a company incorporated in England and Wales. The parent's consolidated financial statements can be obtained from the registered office at 2 Rowles Way, Buckingway Business Park, Swavesey, England, CB24 4UG. The Ultimate controlling party is Citco Jersey Limited as Trustee of the RSJT Trust . The Trust's Financial Statements can be obtained from the registered office of the Trustee at No. 4 The Forum, Grenville Street, St Helier, Jersey JE2 4UF.